In healthcare, advanced technologies have consistently pushed the boundaries of how we understand, diagnose and treat medical conditions. As a physician and researcher, I’ve witnessed firsthand ...

The Future of Precision Medicine. As AI and other technologies used in precision medicine continue to advance, the field is poised to expand significantly in both scope and impact.

If more people got their hands on fresh food—by way of at-home “medically tailored meal” services, “farmacy” produce prescriptions or food banks, and better grocery options overall—than we might be ...

The Path from Proteins to Genes. At Regeneron, we have spent over three decades honing a deep expertise in disease biology and genetics.By rigorously pursuing an understanding of pathobiology ...

The future of healthcare is promising, with growth and innovation led by advancements in regenerative medicine. Companies like Regenity Biosciences are pioneering advancements in regenerative ...

Famous AI Quotes 1. “The future of AI is not about replacing humans, it’s about augmenting human capabilities.” – Sundar Pichai, CEO of Google.

As Medscape marks its 30th anniversary, we are collaborating with physicians, scientists, and futurists to envision the future of medicine in the year 2050. News & Perspective Tools & Reference CME/CE ...

The future of AI in healthcare is promising. AI-powered wearable devices can continuously monitor patients and detect health issues early. AI-assisted surgical robots are improving precision and ...

To learn more about how clinical trials are helping shape the future of medicine, click below. Legacies aren’t just meant to be left, they’re meant to be lived. LEARN MORE. SKIP ...

What was once considered science fiction — remote diagnostics, AI in surgery, 3D-printed organs — has become medical reality. The next 30 years will redefine what it means to be treated, cured and car ...

Discover how Teva is leveraging its unique position across the full spectrum of medicine — from innovative therapies to essential generics and biosimilars — to expand access and improve ...